Proven adherence solutions that drive outcomes HealthBeacon specializes in innovative adherence solutions for medication management. Our flagship product, the Injection Care Management System, improves medication adherence and delivers valuable data insights for patients, family members and clinicians alike. From supporting improved treatment outcomes to fostering a deeper understanding of patient needs, HealthBeacon empowers patients and transforms the landscape of healthcare delivery. In 2024, HealthBeacon was acquired by Hamilton Beach Health, a subsidiary of Hamilton Beach Brands Holding Co. (NYSE: HBB). This marked a significant step forward in our mission to enhance patient outcomes and strengthen our position in the healthcare …

19 similar entities Type: Startup Activities: healthtech Technologies: IoT

Facilitate access to care and health everywhere, for everyone! libheros is an e-health company specializing in the coordination of interventions by health professionals. Thanks to our technology, we facilitate, throughout France, the rapid and reliable mobilization of private caregivers for all types of care. To carry out our projects, we rely on: 👩‍⚕️ A community of more than 20,000 liberal healthcare professionals (nurses, IPAs, physiotherapists, midwives) 💻 Secure digital tools 🤝 A team of expert paramedical coordinators Our services are aimed at several audiences: 🏠 Individuals, who easily and quickly find a healthcare professional for their home care. Every month, …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

BioPharma Asia is the premier publication for unbiased, cutting edge editorial written by the leading figures currently working in the global Pharma and BioPharma industry. With a circulation of 30,000 printed journals throughout Asia and distributed to a controlled circulation of Heads of Manufacturing, Senior Scientists and Middle-Senior Managers throughout Asia on a bi-monthly basis, BioPharma Asia aims to keep its readers abreast of all developments in the areas of Drug Development, Drug Delivery, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles, written by the most respected authors, associated with only end-user companies. This ensures …

Type: Media

Encouraging careful stewardship of clinical genetics, genomics and precision medicine. The Center for Genomic Interpretation (CGI) is an independent non-profit organization with the mission to save and improve lives through encouraging careful stewardship of clinical genetics, genomics, and precision medicine. Clinical Genetics, Human Genetics, Genetics, Variant Classification, Variant Interpretation, Mutation Analysis, Mutation Interpretation, Mutation Classification, Mutation, Service, Diagnostics, Precision Medicine, Genomics, Clinical Genomics, Consumer Genetics, Fraud, Waste, Abuse, and Health Insurance

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech

The intelligence, simulation and forecasting platform for life sciences. Airfinity provides AI-powered intelligence, simulations and forecasting solutions to help life sciences organisations navigate uncertainty. Our advanced models have been built over 10 years and tested at scale. Infectious Diseases, CVRM, Life Sciences, and Forecasting

37 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Data Analytics A.I. - Machine Learning

Pionnier de la thérapie régénératrice cardiaque CellProthera, a biotechnological company, has developed a unique therapeutic technique which enables the structural and functional regeneration of severe post-infarctus cardiac lesions. After European and national (FR/GB) authorization was obtained , CellProthera has started its I/IIB clinical trial in Humans. Heart Regeneration

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

All the sectoral study expertise of the Les Echos-Le Parisien Group at the service of your strategy Les Echos Etudes is the sectoral expertise center of the Les Echos Group (LVMH holding company). Mission: We specialize in the production of market, marketing and strategic studies as well as in the economic and financial diagnosis of companies. We carry out ad hoc studies on behalf of public and private actors (Ministries, major accounts). Experts: Each study is carried out by a specialist consultant in the sector. We equip ourselves with the best experts capable of providing the most relevant analyzes to …

Type: SMB Activities: martech constructiontech healthtech agritech transporttech

Go faster for the Patient, further with the Entrepreneur Jeito is a next-generation fund with a patient benefit driven approach, that focuses both on financing ground-breaking medical innovation and promoting positive societal impact. We empower and support entrepreneurs through our expert, integrated, multi-talented team. Jeito Capital is based in Paris with a presence in Europe and the United States. Follow us to get our latest news & job offers. Private equity and Biopharma

Type: Incubators & VCs

Rewriting the rules of drug creation Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas …

296 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology

The leading global semiconductor venture fund with exclusive access to imec’s expertise and ecosystem. Imec.xpand is a revolutionary way of investing in early stage innovation on the crossroads of technology transfer, corporate venturing and traditional venture capital. The fund will heavily leverage the extensive technology, knowledge, vision and expertise of imec and of its strategic investors, targeting nanoelectronics-based innovation projects in smart applications for a sustainable society such as smart health, smart mobility, smart cities, smart industries, smart energy.

Type: Incubators & VCs